Sort
141,003 grants matching “cytokine”
Commensal-specific T cell function in skin wound repair
$587,319Oliver James Harrison · Benaroya Research Inst At Virginia Mason · R01 · FY2022 · AI
Commensal-specific T cell function in skin wound repair
$587,319Oliver James Harrison · Benaroya Research Inst At Virginia Mason · R01 · FY2024 · AI
Neutralizing the degenerate disc microenvironment to enhance the efficacy of therapeutic stem cells
$587,313Lachlan James Smith · University Of Pennsylvania · R01 · FY2021 · AR
Wnt7a-Mediated Competence to Resist Osteoarthritis Progression
$587,306Li Zeng · Tufts University Boston · R01 · FY2023 · AR
Genetics of atherosclerosis in renal disease
$587,279Muredach P Reilly · University Of Pennsylvania · R01 · FY2008 · DK
LncRNA SNHG12, vascular senescence, and atherosclerosis
$587,250Mark W Feinberg · Brigham And Women'S Hospital · R01 · FY2023 · HL
Cardiac Repair Using Smart Stem Cells
$587,242Muhammad Ashraf · University Of Cincinnati · R01 · FY2008 · HL
Role of mitochondria in SLE and its cardiovascular complications
$587,228Jan Christian Lood · University Of Washington · R01 · FY2023 · HL
Intestinal Resection Associated Liver Injury and Fibrosis
$587,221Brad Wayne Warner · Washington University · R01 · FY2021 · DK
Regenerative Therapies for Inherited Blood Disorders-HSC expansion
$587,214Andre Larochelle · National Heart, Lung, And Blood Institute · ZIA · FY2016 · HL
Single cell opioid (fentanyl) responses in the context of HIV
$587,188Jason T Blackard · University Of Cincinnati · R01 · FY2025 · DA
Dual-payload antibody-drug conjugate for chemo-immunotherapy of triple-negative breast cancers
$587,169Xiaoguang Margaret Liu · Ohio State University · R01 · FY2023 · CA
Novel Inhibitors for Temporal Modulation of T-Lymphocytes during Chronic Heart Failure
$587,161Shyam Sunder Bansal · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2024 · HL
Social Connectedness and Health in the Blackfeet Community: An Investigation of Biopsychosocial Mediators
$587,119Neha John-Henderson · Montana State University - Bozeman · R01 · FY2024 · MD
Therapeutic approaches for LKB1-deficient non-small cell lung cancer
$587,093John V. Heymach · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
Induction of effector lymphocyte lethargy by helminth coinfection
$587,042George S. Yap · Rbhs-New Jersey Medical School · R01 · FY2020 · AI
Induction of effector lymphocyte lethargy by helminth coinfection
$587,042George S. Yap · Rbhs-New Jersey Medical School · R01 · FY2017 · AI
Induction of effector lymphocyte lethargy by helminth coinfection
$587,042George S. Yap · Rbhs-New Jersey Medical School · R01 · FY2018 · AI
Induction of effector lymphocyte lethargy by helminth coinfection
$587,042George S. Yap · Rbhs-New Jersey Medical School · R01 · FY2019 · AI
Induction of effector lymphocyte lethargy by helminth coinfection
$587,042George S. Yap · Rbhs-New Jersey Medical School · R01 · FY2021 · AI
Immune Responses in Otitis Prone Children
$587,036Michael E Pichichero · Rochester General Hospital (Ny) · R01 · FY2012 · DC
Immune injury as a driver for the development of ascending aortic aneurysms and dissections
$587,029Zhihua Jiang · University Of Florida · R01 · FY2021 · HL
Silk-based Formulation for Microbicide Delivery
$587,018Patricia J Liwang · University Of California, Merced · R01 · FY2016 · AI
GENE THERAPY WITH SOCS-3 IN INTIMAL HYPERPLASIA AND IN-STENT RESTENOSIS
$587,008Devendra K. Agrawal · Creighton University · R01 · FY2013 · HL
How does HIV lead to increased susceptibility to tuberculosis?
$586,997David G Russell · Cornell University · R01 · FY2015 · AI